» Articles » PMID: 28490838

Adipokine Contribution to the Pathogenesis of Osteoarthritis

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2017 May 12
PMID 28490838
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies have shown that overweight and obesity play an important role in the development of osteoarthritis (OA). However, joint overload is not the only risk factor in this disease. For instance, the presence of OA in non-weight-bearing joints such as the hand suggests that metabolic factors may also contribute to its pathogenesis. Recently, white adipose tissue (WAT) has been recognized not only as an energy reservoir but also as an important secretory organ of adipokines. In this regard, adipokines have been closely associated with obesity and also play an important role in bone and cartilage homeostasis. Furthermore, drugs such as rosuvastatin or rosiglitazone have demonstrated chondroprotective and anti-inflammatory effects in cartilage explants from patients with OA. Thus, it seems that adipokines are important factors linking obesity, adiposity, and inflammation in OA. In this review, we are focused on establishing the physiological mechanisms of adipokines on cartilage homeostasis and evaluating their role in the pathophysiology of OA based on evidence derived from experimental research as well as from clinical-epidemiological studies.

Citing Articles

Metabolism-Related Adipokines and Metabolic Diseases: Their Role in Osteoarthritis.

Zhang Q, Zhao Y, Li L, Fan Q, Huang B, Du H J Inflamm Res. 2025; 18:1207-1233.

PMID: 39886385 PMC: 11780177. DOI: 10.2147/JIR.S499835.


CYR61 as a Potential Apoptosis Biomarker in Osteoarthritis with Comorbidities.

Tokus M, Cicek H, Ates H, Coskun C, Dogus Y, Cicek F J Musculoskelet Neuronal Interact. 2024; 24(4):385-393.

PMID: 39616508 PMC: 11609561.


A Cross-Sectional Study: Systematic Quantification of Chemerin in Human Cerebrospinal Fluid.

Hopfinger A, Behrendt M, Schmid A, Karrasch T, Schaffler A, Berghoff M Biomedicines. 2024; 12(11).

PMID: 39595074 PMC: 11592017. DOI: 10.3390/biomedicines12112508.


Bioactive Compounds in Osteoarthritis: Molecular Mechanisms and Therapeutic Roles.

Maouche A, Boumediene K, Bauge C Int J Mol Sci. 2024; 25(21).

PMID: 39519204 PMC: 11546619. DOI: 10.3390/ijms252111656.


Obesity-induced fibrosis in osteoarthritis: Pathogenesis, consequences and novel therapeutic opportunities.

Henriques J, Berenbaum F, Mobasheri A Osteoarthr Cartil Open. 2024; 6(4):100511.

PMID: 39483440 PMC: 11525450. DOI: 10.1016/j.ocarto.2024.100511.


References
1.
Junker S, Frommer K, Krumbholz G, Tsiklauri L, Gerstberger R, Rehart S . Expression of adipokines in osteoarthritis osteophytes and their effect on osteoblasts. Matrix Biol. 2016; 62:75-91. DOI: 10.1016/j.matbio.2016.11.005. View

2.
Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S . Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002; 8(11):1288-95. DOI: 10.1038/nm788. View

3.
Wang K, Xu J, Cai J, Zheng S, Han W, Antony B . Serum levels of interleukin-17 and adiponectin are associated with infrapatellar fat pad volume and signal intensity alteration in patients with knee osteoarthritis. Arthritis Res Ther. 2016; 18:193. PMC: 5002102. DOI: 10.1186/s13075-016-1088-9. View

4.
Lovren F, Pan Y, Quan A, Szmitko P, Singh K, Shukla P . Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. Am J Physiol Heart Circ Physiol. 2010; 299(3):H656-63. PMC: 2944489. DOI: 10.1152/ajpheart.00115.2010. View

5.
Koskinen A, Vuolteenaho K, Moilanen T, Moilanen E . Resistin as a factor in osteoarthritis: synovial fluid resistin concentrations correlate positively with interleukin 6 and matrix metalloproteinases MMP-1 and MMP-3. Scand J Rheumatol. 2014; 43(3):249-53. DOI: 10.3109/03009742.2013.853096. View